News
Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
Women taking popular weight-loss drugs have been urged to use effective contraception while taking the medication amid ...
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.
Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...
In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...
The rising trend of sweet-smelling gourmand fragrances coincides with anecdotal reports from GLP-1 weight-loss drug users ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results